metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-61 PREVALENCE OF HEPATITIS E VIRUS INFECTION ON CIRRHOTIC PATIENT POPULATION F...
Información de la revista
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Acceso a texto completo
P-61 PREVALENCE OF HEPATITIS E VIRUS INFECTION ON CIRRHOTIC PATIENT POPULATION FROM ROSARIO
Visitas
209
Julián Acosta1, Alceo Galimberti2, Federico Marziali1, Fernando Bessone2, Alejandro Costaguta3, Hugo Tanno2, Virginia Reggiardo2, Daniela Gardiol1, Ana Laura Cavatorta1
1 Institute of Molecular and Cellular Biology of Rosario-Virology Area/CONICET-UNR, Rosario, Argentina
2 Gastroenterology and Hepatology Service, Centenary Provincial Hospital, Faculty of Medicine-UNR, Rosario, Argentina
3 Gastroenterology and Hepatology Service, Children's Sanatorium / Fundación Dr. J.R. Villalobos, Rosario, Argentina. Fundación Dr. J.R.Villavicencio, Rosario, Argentina
Este artículo ha recibido
Información del artículo
Suplemento especial
Este artículo forma parte de:
Vol. 28. Núm S1

Abstracts of the 2022 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

Hepatitis E virus (HEV), with the zoonotic transmission, is one of the main agents causing acute hepatitis. In individuals with chronic liver disease, the infection can cause acute on chronic liver disease (ACLD) and can lead to fulminant liver failure. This study aimed to analyze the impact of HEV infection in a cohort of cirrhotic individuals from Rosario, Santa Fe.

Materials and Methods

Ninety-seven individuals (18-82 years old; male=61) with liver cirrhosis of different etiology were enrolled; among them, 57 were followed up over two years. Blood samples were obtained every six months and at the time of decompensation of the cirrhosis. IgG and IgM a-HEV were studied by ELISA and HEV RNA by RT-qPCR method optimized in our laboratory. As a control group, 154 blood donors (18-62 years old; male=90) were analyzed.

Results

We demonstrated a seroprevalence of IgG a-HEV of 5.2% (5/97) in the cirrhotic population, compared to 3.2% obtained in the control group (p>0.05). The highest prevalence of IgG a-HEV was recorded in those cirrhotic patients with autoimmune and hepatitis C infection etiology (11.1% and 8.0%, respectively). Among the 57 patients in follow-up, 19 decompensated at least once (6 ACLD) and 18 died. In 3/19 (15.8%) IgG a-HEV was detected; however, only one of them (1/3) seroconverted 13 months after the start of the study, while the other two patients had detectable IgG a-HEV antibodies from the beginning of the study. Nevertheless, in these three individuals, the presence of IgM and HEV RNA was not detected.

Conclusions

Our study shows a higher prevalence of IgG a-HEV in the group of cirrhotic patients compared to the control group. However, no association was found between HEV infection and the decompensation events observed in the analyzed cohort.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos